Business Context and Reporting Period
Company: Bright Minds Biosciences Inc.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: January 2026 (Notice of Annual General Meeting)
Signature Date: June 2, 2026
This filing serves as a notice of the Annual General Meeting and Record Date. It does not contain a financial report or operational update for the period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding corporate governance rather than a financial statement.
Material Changes
No material financial changes or operational updates are disclosed in this filing.
Guidance, Outlook, and Risks
Management Commentary: None provided in this filing.
Guidance/Outlook: Not applicable.
Risks/Contingencies: No specific risks or contingencies are detailed in this notice.
Investor Verification Checklist
- Verify the specific date, time, and location of the Annual General Meeting referenced in Exhibit 99.1.
- Confirm the Record Date for shareholders eligible to vote at the meeting.
- Review the company's most recent Form 40-F or 20-F for actual financial performance data, as this 6-K contains none.